Author:
Barresi Vincenza,Belluardo Natale,Sipione Simonetta,Mudó Giuseppa,Cattaneo Elena,Condorelli Daniele Filippo
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference21 articles.
1. Aghi M, Hochberg F, Breakefield XO . Prodrug activation enzymes in cancer gene therapy. J Gene Med. 2000;2:148–164.
2. Austin EA, Huber BE . A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 1993;43:380–387.
3. Polak A, Scholer HJ . Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21:113–130.
4. Mullen CA, Kilstrup M, Blaese RM . Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 1992;89:33–37.
5. Freeman SM, Abboud CN, Whartenby KA, et al. The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274–5283.
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献